Yang, ZF, Zhang, H, Ma, L, Peng, C, Chen, Y, Wang, J, Green, MR, Li, S and Rosmarin, AG (2013) GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. pp. 2312-2317.

Item Type:	Article
Additional Information:	pubid: 100 nvp_institute: NIBR contributor_address: Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01655 USA, TaiShan Med Univ, Sch Basic Med Sci, Tai An 271016, Shandong, Peoples R China ; Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01655 USA, Dana Farber Canc Inst, Div Genom Stabil & DNA Repair, Dept Radiat Oncol, Boston, MA 02215 USA ; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01655 USA, Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01655 USA, Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA ; Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01655 USA, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA ; Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01655 USA, Novartis Inst BioMed Res, Cambridge, MA 02139 USA ; Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01655 USA alan.rosmarin@umassmed.edu; Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01655 USA; TaiShan Med Univ, Sch Basic Med Sci, Tai An 271016, Shandong, Peoples R China; Rosmarin, A G; Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01655 USA
Date Deposited:	13 Oct 2015 13:13
Last Modified:	13 Oct 2015 13:13
URI:	https://oak.novartis.com/id/eprint/21939